Compound Detail
CHEMBL1130
DOXIFLURIDINE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL1130 |
| Name | DOXIFLURIDINE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | ZWAOHEXOSAUJHY-ZIYNGMLESA-N |
| Active Moiety | CHEMBL185 |
3
Targets
12
Activities
3
Assay Types
10
PK Parameters
20
Publications
10
Known Names
1
Indications
3
Mechanisms
Molecular Properties
246.2
MW (Da)
-1.69
ALogP
6
HBA
3
HBD
104.5
PSA (Ų)
0.55
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| DNA disrupting agent | DISRUPTING AGENT | DNA | ✓ | ✓ |
| RNA disrupting agent | DISRUPTING AGENT | RNA | ✓ | ✓ |
| Thymidylate synthase inhibitor | INHIBITOR | Thymidylate synthase | ✓ | ✓ |
Indications
Stomach Neoplasms
Activity Summary
IC50 9 meas. best 5.52
EC50 2 meas. best 4.57
Ki 1 meas.
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 11.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.7 | mL.min-1.kg-1 | Homo sapiens |
| CL | 11.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 11.0 | mL.min-1.kg-1 | Homo sapiens |
| Fu | 0.61 | - | Homo sapiens |
| Fu | 0.61 | - | Homo sapiens |
| MRT | 0.46 | hr | Homo sapiens |
| T1/2 | 250.0 | hr | - |
| T1/2 | - | hr | - |
| T1/2 | 0.35 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 405 |
| 7131481 | 10.1021/jm00351a006 | Mus musculus | 24 |
| 8277499 | 10.1021/jm00078a006 | Mus musculus | 20 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 533880 | 10.1021/jm00197a010 | Sarcoma-180 | 6 |
| 7120290 | 10.1021/jm00350a024 | Mus musculus | 6 |
| 17683933 | 10.1016/j.bmcl.2007.07.033 | SW-620 | 5 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 7120290 | 10.1021/jm00350a024 | L1210 | 4 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| 19445515 | 10.1021/jm900403j | Homo sapiens | 2 |
| 2967375 | 10.1021/jm00401a008 | Uridine phosphorylase 1 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 533880 | 10.1021/jm00197a010 | Mus musculus | 2 |
| 2967375 | 10.1021/jm00401a008 | ADMET | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 2 |
Data from ChEMBL 36 via Core Engine